Page last updated: 2024-11-03

pyridinolcarbamate and Liver Cirrhosis

pyridinolcarbamate has been researched along with Liver Cirrhosis in 1 studies

Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
" The patient received since four years pyridinolcarbamate (Prodectin) because of obliterating peripheral arteriosclerosis."3.67[Pyridimocarbamate (prodectin)-induced acute liver damage, cirrhosis and primary liver cancer--accidental finding?]. ( Kendrey, G; Kiss, F; László, B, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kendrey, G1
Kiss, F1
László, B1

Other Studies

1 other study available for pyridinolcarbamate and Liver Cirrhosis

ArticleYear
[Pyridimocarbamate (prodectin)-induced acute liver damage, cirrhosis and primary liver cancer--accidental finding?].
    Morphologiai es igazsagugyi orvosi szemle, 1989, Volume: 29, Issue:1

    Topics: Acute Disease; Arteriosclerosis; Carbamates; Chemical and Drug Induced Liver Injury; Female; Humans;

1989